| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -41.2% |
| Cost of Revenue | $574K | -37.1% |
| Gross Profit | $475K | -36.8% |
| R&D Expense | $8.1M | +19.9% |
| SG&A Expense | $7.1M | -2.4% |
| Operating Income | -$14.7M | -10.9% |
| Pre-tax Income | -$13.8M | -18.7% |
| Income Tax | $2K | +0.0% |
| Net Income | -$13.8M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Short-term Investments | $15.1M | -29.6% |
| Accounts Receivable | $485K | +529.9% |
| Current Assets | $22.0M | -36.7% |
| Total Assets | $27.0M | -28.3% |
| Current Liabilities | $2.5M | -3.0% |
| Total Liabilities | $4.9M | +72.6% |
| Stockholders' Equity | $22.1M | -36.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | -33.2% |
| Capital Expenditures | $833K | +43.9% |
| Investing Cash Flow | $5.8M | -5.6% |
| Financing Cash Flow | -$185K | -2.2% |
| Free Cash Flow | -$13.8M | -33.8% |
| -18.7% |
| EPS (Basic) | -$8.32 | -16.9% |